The Extent of Liver Steatosis in Chronic Hepatitis C Virus Infection Is Mirrored by Caspase Activity in Serum *
Authors:
Open Access
- 26 May 2005
- journal article
- viral hepatitis
- Published by Wolters Kluwer Health in Hepatology
- Vol. 42 (1) , 113-120
Abstract
Hepatic steatosis is a frequent histological alteration in chronic hepatitis C virus (HCV) infection that sensitizes the liver to cell injury, inflammation, and fibrosis via unclear mechanisms. Although apoptosis has been implicated in various liver diseases, its importance in HCV-associated steatosis is largely unknown. In this study, we investigated the role of caspases, the key regulators of apoptosis, and employed two novel caspase assays, an immunological and a luminometric enzyme test, to detect hepatic caspase activation in sera from HCV patients with different grades of steatosis. Our data show that increased caspase activation can be found not only in liver biopsies, but also in sera from HCV patients with liver steatosis. Patients with steatosis exhibited significantly higher serum levels of caspase activity compared with normal healthy individuals. Moreover, the extent of steatosis closely correlated with serum caspase activity, whereas in particular in cases of low or moderate steatosis, no correlation was found with aminotransferase levels. In conclusion , apoptotic caspase activation is considerably elevated in HCV-associated steatosis. More importantly, our data imply that measurement of caspase activation might be a sensitive serum biomarker to detect liver steatosis in patients with chronic HCV infection and other liver diseases. (Hepatology 2005.)Keywords
This publication has 49 references indexed in Scilit:
- p53 Involvement in the Pathogenesis of Fatty Liver DiseaseJournal of Biological Chemistry, 2004
- Steatosis and liver cell apoptosis in chronic hepatitis C: A mechanism for increased liver injuryHepatology, 2004
- Fatty acids enhance membrane permeabilization by pro-apoptotic BaxBiochemical Journal, 2004
- Effect of Treatment With Peginterferon or Interferon Alfa–2B and Ribavirin on Steatosis in Patients Infected With Hepatitis CHepatology, 2003
- Inflammation in response to hepatocellular apoptosisHepatology, 2002
- Detection of elevated caspase activation and early apoptosis in liver diseasesEuropean Journal of Cell Biology, 2001
- In situ monitoring of caspase activation in hepatobiliary diseasesCell Death & Differentiation, 2000
- Steatohepatitis: A tale of two “hits”?Gastroenterology, 1998
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis CHepatology, 1994